ECRS Company Profile

11:46 EST 23rd November 2017 | BioPortfolio

News Articles [2 Associated News Articles listed on BioPortfolio]

Novartis’ Alcon to introduce new Clareon intraocular lens

Novartis subsidiary Alcon is set to introduce new Clareon intraocular lens (IOL) at this year’s European Society of Cataract and Refractive Surgeons (ECRS) congress in Portugal.

Funding available for Biotechnology and Bioenergy Research

The BBSRC, with support from EPSRC, have committed £18M to fund 13 unique collaborative Networks in Industrial Biotechnology and Bioenergy (BBSRC NIBB).The ‘Crossing Biological Membranes&r...

Drugs and Medications [0 Results]


PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Expression of cysteinyl leukotriene receptor GPR17 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.

The cysteinyl leukotrienes (cysLTs) are proinflammatory lipid mediators that act on the type 1 cysLT receptor (CysLT1R) in the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP). GPR17,...

Clinical Trials [0 Results]


More Information about "ECRS" on BioPortfolio

We have published hundreds of ECRS news stories on BioPortfolio along with dozens of ECRS Clinical Trials and PubMed Articles about ECRS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ECRS Companies in our database. You can also find out about relevant ECRS Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record